The relationship between serum 25(OH)D and parathyroid hormone levels

Area of Science:

• Endocrinology
• Nutritional Science
• Bone Metabolism

Background:

• Low vitamin D (25(OH)D) levels are linked to elevated parathyroid hormone (PTH), contributing to bone loss.
• Optimal 25(OH)D levels for preventing bone loss by regulating PTH remain unclear.

Purpose of the Study:

• To investigate the relationship between serum 25(OH)D and PTH levels.
• To determine the 25(OH)D threshold required for PTH suppression and prevention of secondary hyperparathyroidism.

Main Methods:

• Retrospective analysis of 19,172 concomitant 25(OH)D and PTH tests from Clalit Health Services laboratory database (2009).
• Statistical analysis including correlation and quadratic modeling to identify PTH-25(OH)D relationships.
• Subgroup analysis excluding individuals with hypercalcemia or renal failure.

Main Results:

• A significant inverse correlation (r = -0.176, P < .001) was observed between 25(OH)D and PTH levels.
• PTH levels increased sharply below 50 nmol/L 25(OH)D, plateauing around 75-85 nmol/L (stabilization at 78.9 nmol/L).
• In individuals with normal renal function, the PTH plateau was reached at a lower 25(OH)D level of 46.2 nmol/L.

Conclusions:

• A 25(OH)D threshold of 50 nmol/L appears sufficient to suppress PTH and prevent secondary hyperparathyroidism in individuals with normal renal function.
• Vitamin D levels exceeding 75 nmol/L do not appear to offer additional benefits in lowering PTH levels.